Itron (NASDAQ:ITRI) Earns "Buy (B)" Rating from Weiss Ratings

Key Points

• Itron's stock has been reaffirmed with a "Buy (B)" rating by Weiss Ratings, indicating increased analyst confidence in the company's performance.
• As per recent reports, Itron's stock has an average price target of $137.10 with a consensus rating of "Moderate Buy" from ten analysts.
• The company recently beat earnings expectations with an EPS of $1.62 for the quarter, while it had set FY 2025 guidance at 6.000-6.200 EPS.

Itron (NASDAQ:ITRI - Get Free Report)'s stock had its "buy (b)" rating reaffirmed by Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.

Several other equities analysts have also recently issued reports on ITRI. Stephens restated an "equal weight" rating and set a $130.00 price objective on shares of Itron in a research note on Tuesday. Roth Capital raised their price objective on Itron from $130.00 to $150.00 and gave the stock a "buy" rating in a research note on Tuesday, July 22nd. Guggenheim restated a "buy" rating and set a $155.00 price objective (up from $133.00) on shares of Itron in a research note on Monday, July 14th. Wall Street Zen upgraded Itron from a "hold" rating to a "buy" rating in a research note on Friday, October 3rd. Finally, JPMorgan Chase & Co. upgraded Itron from a "neutral" rating to an "overweight" rating and raised their price objective for the stock from $128.00 to $145.00 in a research note on Thursday, July 31st. Ten equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $137.10.

Itron Stock Performance

Itron stock opened at $127.52 on Wednesday. The stock has a market cap of $5.83 billion, a P/E ratio of 21.80, a price-to-earnings-growth ratio of 0.69 and a beta of 1.48. The company has a current ratio of 2.04, a quick ratio of 1.75 and a debt-to-equity ratio of 0.48. The stock has a 50 day moving average of $123.40 and a 200-day moving average of $119.55. Itron has a 52 week low of $90.11 and a 52 week high of $140.04.

Itron (NASDAQ:ITRI - Get Free Report) last released its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%.The company had revenue of $606.76 million during the quarter, compared to analysts' expectations of $610.36 million. During the same period in the prior year, the business posted $1.21 EPS. The business's revenue was down .4% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, analysts expect that Itron will post 5.33 EPS for the current fiscal year.

Insider Transactions at Itron

In other Itron news, SVP Christopher E. Ware sold 351 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $43,983.81. Following the sale, the senior vice president directly owned 19,117 shares of the company's stock, valued at $2,395,551.27. This trade represents a 1.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Joan S. Hooper sold 970 shares of the firm's stock in a transaction on Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $121,550.70. Following the transaction, the chief financial officer directly owned 88,394 shares in the company, valued at $11,076,652.14. This trade represents a 1.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 3,037 shares of company stock valued at $380,566 over the last three months. 1.45% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ITRI. Impax Asset Management Group plc acquired a new position in shares of Itron during the second quarter valued at $91,998,000. Norges Bank acquired a new position in shares of Itron during the second quarter valued at $71,727,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Itron by 129.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company's stock valued at $76,713,000 after purchasing an additional 413,487 shares during the period. Merewether Investment Management LP increased its holdings in shares of Itron by 1,552.7% during the second quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company's stock valued at $39,593,000 after purchasing an additional 282,587 shares during the period. Finally, Handelsbanken Fonder AB increased its holdings in shares of Itron by 21.2% during the second quarter. Handelsbanken Fonder AB now owns 943,564 shares of the scientific and technical instruments company's stock valued at $124,201,000 after purchasing an additional 165,300 shares during the period. 96.19% of the stock is owned by institutional investors and hedge funds.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.